R-2HG can block the post-transcriptional upregulation of PFKP and LDHB mediated by FTO/m6A, thus attenuating aerobic glycolysis in sensitive(IDH-wildtype) leukemic cells and inhibiting the occurrence of leukemia [118]. Here, PFKP is linked to leukemia.